JSM2023
Back to all people

Kit Roes

European Medicines Agency, Radbound University, The Netherlands
1 appearance in the program

Sessions & presentations

Decentralized Trials for Rare Diseases: What are the Benefits and Risks?
Presentation: Design and regulatory considerations for decentralized clinical trials in rare diseases
Topic-Contributed Paper Session · Wed, Aug 9 , 2:00 PM
Speaker
↑